{"id":"W4213017736","doi":"10.1097/01.cot.0000821988.50798.78","title":"Durvalumab + Tremelimumab Improves Survival in Advanced Liver Cancer","year":2022,"lang":"en","type":"article","venue":"Oncology Times","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tremelimumab; Durvalumab; Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Oncology; Cancer; Liver cancer; Immunotherapy; Gastroenterology; Nivolumab; Ipilimumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002525597,0.0001900573,0.0003532409,0.0001501787,0.000112941,0.0002254675,0.0001406139,0.0001297053,0.001429796],"category_scores_gemma":[0.0002353016,0.00005400779,0.0002754017,0.0001152464,0.00006460096,0.0001569819,0.0001406462,0.0003708463,0.0002145364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004057718,"about_ca_system_score_gemma":0.0003522428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008235674,"about_ca_topic_score_gemma":0.003867033,"domain_scores_codex":[0.9999354,0.00001701167,0.000005340563,0.000008508766,0.00001693007,0.00001681431],"domain_scores_gemma":[0.9999368,0.00001033138,0.00001273344,0.0000044713,0.000009289779,0.00002634918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02139404,0.001785689,0.0117997,0.0005340576,0.0004303601,0.0003280058,0.00007421175,0.0007199496,0.05267478,0.0002706751,0.009015361,0.9009733],"study_design_scores_gemma":[0.051513,0.1205918,0.5729414,0.0004521298,0.003593018,0.007221039,0.0002595026,0.01038816,0.0783084,0.001679826,0.1529578,0.00009403798],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628121,0.03001051,0.0004132018,0.00183308,0.0002013307,0.00005292384,0.0001802073,0.0001494123,0.004347299],"genre_scores_gemma":[0.9898027,0.007041593,0.0005974017,0.0005619985,0.0001329932,0.00002127315,0.0003021646,0.000008758085,0.001531221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001429796,"threshold_uncertainty_score":0.004783154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04887956912497531,"score_gpt":0.2980527105966843,"score_spread":0.249173141471709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}